Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chimeric Therapeutics Ltd. (AU:CHM)
:CHM
CHM Stock Chart & Stats
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.04
Previous CloseN/A
Volume2.58M
Average Volume (3M)3.14M
Market Cap
AU$11.17M
Enterprise ValueAU$14.47M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.49
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding1,595,149,900
10 Day Avg. Volume6,244,913
30 Day Avg. Volume3,140,386
Standard Deviation0.19
R-Squared0.19
Alpha-0.07
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)21654.24
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Chimeric Therapeutics Ltd. News
PremiumCompany Announcements
Chimeric Therapeutics Expands Capital with ASX Quotation
PremiumCompany Announcements
Chimeric Therapeutics Issues New Shares to Boost Funding
PremiumCompany Announcements
Chimeric Therapeutics Expands CHM CDH17 Clinical Trial with UChicago Medicine
PremiumCompany Announcements
Chimeric Therapeutics Advances Clinical Trials and Strengthens Leadership
PremiumCompany Announcements
Chimeric Therapeutics Issues 55 Million Unquoted SecuritiesPremiumCompany Announcements
Chimeric Therapeutics Ceases Over 5 Million Securities
PremiumCompany Announcements
Chimeric Therapeutics Issues Unquoted Equity Securities
PremiumCompany Announcements
Chimeric Therapeutics Advances Innovative AML Trial---
Options Prices
Currently, No data available
---
Ownership Overview
CHM FAQ
What was Chimeric Therapeutics Ltd.’s price range in the past 12 months?
Chimeric Therapeutics Ltd. lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is Chimeric Therapeutics Ltd.’s market cap?
Chimeric Therapeutics Ltd.’s market cap is AU$11.17M.
When is Chimeric Therapeutics Ltd.’s upcoming earnings report date?
Chimeric Therapeutics Ltd.’s upcoming earnings report date is Aug 28, 2025 which is in 188 days.
How were Chimeric Therapeutics Ltd.’s earnings last quarter?
Currently, no data Available
Is Chimeric Therapeutics Ltd. overvalued?
According to Wall Street analysts Chimeric Therapeutics Ltd.’s price is currently Overvalued.
Does Chimeric Therapeutics Ltd. pay dividends?
Chimeric Therapeutics Ltd. does not currently pay dividends.
What is Chimeric Therapeutics Ltd.’s EPS estimate?
Chimeric Therapeutics Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chimeric Therapeutics Ltd. have?
Chimeric Therapeutics Ltd. has 1,595,149,900 shares outstanding.
What happened to Chimeric Therapeutics Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Chimeric Therapeutics Ltd.?
Currently, no hedge funds are holding shares in AU:CHM
---
Chimeric Therapeutics Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:CHM Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth AU$800.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
-308.21%
Trailing 12-Months
Asset Growth
-31.74%
Trailing 12-Months
Company Description
Chimeric Therapeutics Ltd.
Chimeric Therapeutics Ltd is a biotechnology company engaged in developing a cancer cell therapy drug. Its technology CLTX-CAR T uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor-targeting component of the CAR to reprogram T cells.
---
Biotron Limited
―
Opthea Limited
―
Imugene Limited
―
Patrys Limited
―
Race Oncology Ltd.
―
---